Plain-English translation of NCT06587256 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing silicone mouth tape as a simple way to help people with snoring and mild sleep apnea. Snoring affects millions of people worldwide and can reduce sleep quality for both the person snoring and their bed partner. Researchers want to see if this medication can help people breathe better through their nose at night and reduce snoring.
Snoring is often dismissed as harmless, but it can actually cause daytime tiredness, poor sleep quality, and even increase stroke risk. Current treatments like CPAP machines or oral appliances are expensive and often not covered by insurance, so doctors are looking for simpler, more affordable options.
You likely qualify if…
You likely don't qualify if…
You would wear silicone mouth tape during sleep to help keep your mouth closed and encourage nasal breathing. The study involves 100 participants with snoring or mild sleep apnea, and researchers will monitor how the tape affects your snoring and sleep quality. You would need a bed partner who can observe and report on changes in your snoring.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United States
Testing effectiveness
Sponsor
Johns Hopkins University
Enrollment target
~100 participants
Started
March 2027
Primary completion
October 2030
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mariah Potocki Study Coordinator
Johns Hopkins University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.